WASHINGTON, Feb 28 (Reuters) - Some of the most prominent voices within Donald Trump's MAGA movement spoke out on Saturday against his attack on Iran, warning it could hurt Republicans in November's ...

A 45-year-old employee of a major trading firm who is obsessed with the U.S. military was arrested on suspicion of illegally entering a base in Japan using a fake ID. Kanagawa prefectural police ...

Exclusive: approximately 350-acre compound planned as base for multinational force, according to records reviewed by the Guardian The Trump administration is planning to build a 5,000-person military ...

US president Donald Trump reportedly withdrew his support for the British prime minister’s Chagos Islands deal because the UK is blocking America from using RAF bases to launch an attack on Iran.

Attention, gamers: if you thought new titles on top of the endless cavalcade of sequels and remakes were derivative now, wait till you hear about what the game engine maker Unity has got in store.

Making a video game usually means learning to code, working with complex game engines, and spending hours piecing everything together. That is true even for simple casual games. Many aspiring ...

The new AI-powered crypto trading platforms are aimed at replacing traditional trading charts and order books with trading execution offered through natural language processing. Update Jan. 21, 9:27 a ...

Baby KJ was the first to receive a bespoke gene-editing treatment. Personalized drugs for others could be approved within the next few years. Kyle “KJ” Muldoon Jr. was born with a rare genetic ...

Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute lymphoblastic leukemia (T-ALL). This form of therapy used genome editing ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest forms of blood cancer, T-cell acute lymphoblastic leukaemia. By precisely ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...